chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Severe pain; Fever; Headache; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Severe pain), PYREXIA (Fever), HEADACHE (Headache) and NAUSEA (Nausea) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 007B21A and 023M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 20-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 20-Mar-2021, the patient experienced PAIN (Severe pain), PYREXIA (Fever), HEADACHE (Headache) and NAUSEA (Nausea). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PAIN (Severe pain), PYREXIA (Fever), HEADACHE (Headache) and NAUSEA (Nausea) outcome was unknown.            No relevant concomitant medications were reported.   Action taken with mRNA-1273 in response to the events was not applicable.   This case was linked to MOD-2021-053275 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 10-May-2021: Follow up received on 10 May 2021 included reporter information
rash at injection site; This non-serious case was reported by a other health professional via sales rep and described the occurrence of injection site rash in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   In SEP-2023, the patient received Shingrix. In SEP-2023, an unknown time after receiving Shingrix, the patient experienced injection site rash (Verbatim: rash at injection site).  The patient was treated with steroids nos (Steroids) and benadryl (nos) (Benadryl). The outcome of the injection site rash was not resolved.   It was unknown if the reporter considered the injection site rash to be related to Shingrix.     It was unknown if the company considered the injection site rash to be related to Shingrix.   Additional Information: GSK receipt date: 12-SEP-2023 The patient received Shingrix vaccine last week. Today (on the day of reporting) the patient came to the office with rash at injection site. The patient was treated with steroids and Benadryl. The medical assistant wanted to know if 2nd dose was appropriate for that patient. The reporter consented to follow up.
Pt called on 12-15-08 to report adverse event from yellow fever vaccine given 12-10-08. Symptoms started on 12-11-08 when she woke up. At that time she had hot feeling (she didn't take her temperature), nausea, cough and nasal congestion.  On 12-12-08 nasal congestion , hot feeling, cough and fatigue continued. Pt states she vomited X 1. on 12-13-08 and 12-14-08 she started to improve. Today 12-15-08 she is improving but still has nasal congestion, cough and fatigue. She has not sought care.  She reported the symptoms to our office today because it was suggested on the Vis.
Hospitalization for acute respiratory failure, COVID. Treated with dexamethasone, zinc 50 mg daily, vitamin D3 50 mcg daily and vitamin C 1,000 mg daily.
pt received both vaccine injections on 1-8-21 and 2-3-21 and then on 5-3-21 was diagnosed with covid
Developed swelling and rash two days post injection/minor pain and soreness at injection site. At 7 days, injection site still had small rash but arm now has a large hard lump (induration) approx. 1" x 3" with slight pain when pressed. No sign of infection, no temperature, or other symptoms. At 14 days (today), induration is still present, but reduced in size to 1/2" x 2", no residual pain.
Rash all over body, could not breath, high blood pressure, fast heart rate, itching skin, dizzy.
Unexplained idiopathic hives, pe and dvt blood clots, pulmonary embolism since 06/12/2021. Hives being treated with steroids and xolair injections and still having bad episodes, 3 trips to the ER. Pe and Dvt blood clots being treated with blood thinners  Apixaban till  02/2022
Swelling, induration, erythema, warmth and tenderness of thigh at site of Kinrix administration. Induration/dark erythema 3.5 x 4 cm, lighter erythema 8.5 x 9 cm.
Numbness facial/ occasional numbness on her cheeks; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (Numbness facial/ occasional numbness on her cheeks) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced HYPOAESTHESIA (Numbness facial/ occasional numbness on her cheeks). At the time of the report, HYPOAESTHESIA (Numbness facial/ occasional numbness on her cheeks) had not resolved.            No Concomitant Medication available.  No Treatment Medication available.  A week after the first dose patient felt slight numbness intermittently over the right cheek area.  The patient still had numbness on cheeks but not as bad as when got the vaccine. The patient reported had the teeth and eyes checked and the physician informed that the numbness could be the result of the vaccine. The patient also mentioned that the reported lot numbers were wrong but did not provide the corrected one.   This case was linked to MOD-2021-060014 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 13-Jul-2021: Batch numbers were deleted. Event verbatim and outcome, action taken and narrative was updated.
HIVES, ITCHING OF HANDS, ARMS, LEGS, FACE AND THROAT, NUMBNESS IN LEFT HAND 50MG BENADRYL IM GIVEN 4 HOURS AFTER SHOT WAS ADMINISTERED
Rash on left arm starting 1.5 inches down from the injection site. Red spots ranging from small to large distributed on the arm towards the elbow. Red spots are warm to the touch and entire area is swollen. Injection site does not appear to be swollen at the first notice of the rash (2 days post second round vaccination).
Patient received Covid shot at 6pm yesterday. She had to wait 30 mins due to previous allergic reactions. (1st covid shot) Called pharmacy today to report that she passed out and was having trouble breathing. I advised her to hang up and call 911. I then called 911 and gave them her name and address.    I called her back about 1 hr later with no answer.  1 hour later, she called me back. She told me she did not go to ER and refused care. She was feeling better. She had a runny/stuffy nose after her shot yesterday. She has an infection on her foot and was changing the dressing and passed out. She has a "bad heart". When she woke up her heart was racing and had shortness of breath. She has also been told by dr she may have seizures.  Since she had not passed out in a while, she thought it might be due to her covid vaccine. I told her these were not normal side effects from a covid vaccine but if she had anymore trouble to go to er and let me know. I also told her to follow up with her heart dr.
Myalgia, Diarrhea,  Localized pain; fatigue Narrative:  Other Relevant History:
48 patients received an expired vaccine; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (48 patients received an expired vaccine) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Nov-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (48 patients received an expired vaccine). On 15-Nov-2021, EXPIRED PRODUCT ADMINISTERED (48 patients received an expired vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant Medications were provided by the reporter  No Treatment Information were provided by the reporter
Symptoms: Headache fatigue, sinus problems. Coughing was like allergy symptoms. Gave me a cough medication, when I woke up- flushing started from my head to my feet. Chills. Checked my temperature 99.8 through the whole thing. That was the only fever I ever had. Worse part was the fatigue  On the 18 of May, which was the day I got my vaccine. That was also my son-in-law?s birthday. We were within close spaces for about 45 minutes. We were all here having a pizza party. And my husband took a rapid test on the 19th in the middle of the night and it came back positive. I felt like I had a sinus infection.    I tested positive on the 23rd. On the 24th, I got Paxlovid, then because there was only 2 of us in the house, I didn?t have to isolate and my husband already finished his 5 days. He stayed for the full 10 days and so did I. the worst symptom I experienced was the fatigue. It made me very tired and some brain fog. That may have been from just being so tired. I had a fever that first day. Took a long nap then had that flushing feeling and shivering. That was about 45 minutes. Checked my fever and it was 99.8 and took some Tylenol. I didn?t feel too bad through all of that other than being tired.   Also I have fluid behind my ears. Haven?t had this before, unsure if this in relation to the COVID infection, but this has been going on for 3 weeks. Usually, fluid behind ears could mean an infection. Affecting my hearing. Using a cortisone nasal spray and Zyrtec. Also taking a steroid pack for this and not seeing too much improvement.
Pt reported sneezing en route home then ears, eyes, and face started to itch. Pt left ER at 0855. Returned at 1049 for Tx. Was given Benadryl 50mg PO, itching stopped at 1125 until discharge at 1500.
Patient diagnosed with intussusception to hepatic flexure on 8/12/10 (3 months of age). On 7/22/10, she was given ROTATEQ, (DTaP, Hib, and IVP=>PENTACEL), and PREVNAR.
STEMI on 3/18/2021.  Thrombosis in LAD.  Minimal coronary artery disease on cath.
patient went into V Fib cardiac arrest at home, EMS was called patient was shocked 3 x received 4 epinephrine pushes, 1 amiodarone 300mg and ROSC was achieved and went to hospital.
was suppose to take my 2nd dose of my vaccine April 30th; Cold; Soreness of the arm; chills; Headache; This spontaneous case was reported by a consumer and describes the occurrence of NASOPHARYNGITIS (Cold), PAIN IN EXTREMITY (Soreness of the arm), CHILLS (chills), HEADACHE (Headache) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (was suppose to take my 2nd dose of my vaccine April 30th) in a 25-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 02-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 02-Apr-2021, the patient experienced NASOPHARYNGITIS (Cold), PAIN IN EXTREMITY (Soreness of the arm), CHILLS (chills) and HEADACHE (Headache). On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (was suppose to take my 2nd dose of my vaccine April 30th). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form. At the time of the report, NASOPHARYNGITIS (Cold), PAIN IN EXTREMITY (Soreness of the arm), CHILLS (chills), HEADACHE (Headache) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (was suppose to take my 2nd dose of my vaccine April 30th) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) and mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication was not reported by reporter. Patient missed the second of dose of vaccination as she feel sick.   Most recent FOLLOW-UP information incorporated above includes: On 01-Jun-2021: Significant Follow up appended
No adverse reaction. Flu vaccine given too early. Patient contacted, and no symptoms developed after injection.
Flu-like Symptoms; Fever of 101 to 102 degrees; Chills; Fatigue; Dizziness; Headache; Vomiting; Coughing; Sneezing; Diarrhea; Sick; This case was reported by a consumer via call center representative and described the occurrence of flu-like symptoms in a 65-year-old female patient who received HAV (Havrix adult) for prophylaxis.   On 10th February 2020, the patient received Havrix adult. On 11th February 2020, 1 days after receiving Havrix adult, the patient experienced flu-like symptoms, fever, chills, fatigue, dizziness, headache, vomiting, cough, sneezing, diarrhea and sickness. On 14th March 2020, the outcome of the flu-like symptoms, fever, chills, fatigue, dizziness, headache, vomiting, cough, sneezing, diarrhea and sickness were recovered/resolved.   The reporter considered the flu-like symptoms, fever, chills, fatigue, dizziness, headache, vomiting, cough, sneezing, diarrhea and sickness to be related to Havrix adult.  Additional details were as follows: The patient was vaccinated with Havrix on left arm. On next day after vaccination patient experienced flu-like symptoms and she was sick with fever of 101 to 102 degree F, chills, fatigue, dizziness, headache, vomiting, coughing, sneezing, and diarrhea. The patient stated that symptoms lasted until 14th March 2020 and now did not had any of those symptoms. The reporter stated she was going to call MERCK and report that she had the same symptoms with their Hepatitis A vaccine. The patient stated that symptoms were the result of the vaccines for Hepatitis A she received manufactured by GSk and MERCK. The reporter consent to follow up.
This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A patient (no qualifiers provided) received bnt162b2 (BNT162B2), administration date Oct2021 (Batch/Lot number: unknown) as dose 3 (booster), single for Covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Dose 1, Manufacturer Unknown), administration date: Mar2021, for Covid-19 Immunization, reaction(s): "the vaccine in Mar or Apr last year and then I got Covid pretty bad in Aug", "the vaccine in Mar or Apr last year and then I got Covid pretty bad in Aug"; Covid-19 vaccine (Dose 2, Manufacturer Unknown), administration date: Mar2021, for Covid-19 Immunization, reaction(s): "the vaccine in Mar or Apr last year and then I got Covid pretty bad in Aug"; Covid-19 vaccine (Dose 2, Manufacturer Unknown), administration date: Apr2021, for Covid-19 Immunization, reaction(s): "the vaccine in Mar or Apr last year and then I got Covid pretty bad in Aug". The following information was reported: PAROSMIA (non-serious), outcome "not recovered", described as "Smell burning all the time"; PERIPHERAL SWELLING (non-serious), outcome "unknown", described as "Under my arm started swelling up"; SWELLING (non-serious) with onset 25Feb2022, outcome "unknown", described as "Whole chest is swollen". Additional information: Patient had the shot, the vaccine in Mar or Apr last year and then got Covid pretty bad in Aug and then patient had the booster in Oct and now all of a sudden patient smell burning all the time, for like two months now patient had been smelling burning in house and patient searched everywhere and then all whatever 'the clothes patient wear' whatever under patient arm started swelling up and today patient's whole chest was swollen almost like it was like it's fluid'. Patient inquired was that a side effect from the Vaccine. Patient was on the way to the hospital (further not clarified) now because patient's whole chest was swelling up. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Patient was in observation area and began feeling warm and lightheaded. Immunizer immediately attended to patient, no other symptoms present. Patient loosened neck and sleeves of clothing, cool compress applied to back of neck and patient placed head between legs. Symptoms began to resolve within seconds. Patient remained in area for another 20 minutes, pallor returned to normal, patient was ambulating without symptoms. Offer was made to patient to arrange additional help or transportation to medical office, patient declined.
On February the second a couple months after my vaccine I had COVID. I had pain on the right side of my body, it was pretty intense. It was only on the right side of my whole body. After a couple of days I started feeling pressure in my chest like lower raspatory and I also had a cough. I took Ibuprofen for the pain.
After I took the flu shot at 8:00 PM. I got very sick at 03:00 the next morning. I went to the ER where I work and my blood work was normal. Six days later I was very ill and went to the ER and my hemaglobin was 8.4 down the week before from 16.2.
10 minutes after receiving the second dose of Pfizer, pt expressed that she was dizzy, lightheaded, and didn?t feel well.
Received Flu vaccine on 11/13/00. On 11/14/00, developed numbness and tingling in bilateral feet, increased symptoms up both legs, feeling of heaviness and numbness and pain with difficulty ambulating. Denies any upper extremity symptoms. No SOB. IVIG 27gh IV X 5 days. Dx: GBS. Discharged on 11/28/2000; 60 day follow up states the pt still has residual leg weakness.
bladder infections; This is a spontaneous report from a contactable consumer or other non hcp. A 84-years-old patient of an unspecified gender received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection), dose 1 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as DOSE 1, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported.  on an unspecified date the patient experienced bladder infections Therapeutic measures were taken as a result of bladder infections (cystitis). Outcome of the events was unknown.    Information of lot/batch number has been requested.  Follow-up attempts are completed. No further information is expected.
Fever to 101.4 off and on for 2 days following vaccine administration. Baby also slept more for next 2 days. Baby was more fussy than usual for 2 days following vaccine administration.
about 15 hrs  followiing the Covid booster shot, experienced heavy shacking of arms and lower legs, low grade  temperature, fatigue, had to search for words, no chills, poor balance. Symtems lasted2- 3 days
I thought I was getting a sore throat, but then I realized it didn't hurt, it was like I had a lump in my throat. I was alone so I hurried home and took Tylenol. The swelling subsided.
Headache, Myalgia, Diarrhea, NauseaVomiting, Fatigue, chills Narrative:
Pediatric Pfizer Vaccine Lot Number FK5127, was improperly stored in an Immunizations Freezer that maintained a temperature between -15 Celsius and -24 Celsius. Per the Manufacture?s guidelines the vaccine must be stored in a Refrigerator maintaining temperature of 2-8 Degrees Celsius or an Ultra-Low Cold Freezer maintaining temperature of -90C or lower. The patient received the vaccine that was improperly stored.  Treatment: Not required, patient did not report any adverse reactions to the Vaccine.  Outcome: Patient?s guardian notified and offered to restart the Pediatric Pfizer Covid Vaccine series again stored at the proper temperature.  Signs, Symptoms course, etc. None reported by the patient?s guardian
Pfizer-BioNTech COVID-19 vaccine EUA Moderate injection site soreness and stiffness, mild body aches, chills, headache and runny nose  Symptoms started within 12 hours of receiving.
This case was reported by a nurse and described the occurrence of inappropriate age at vaccine administration in a 15-month-old male patient who received BOOSTRIX (batch number 472S7, expiry date 13th April 2016). The patient's past medical history included no adverse. Concomitant products included Hib vaccine. On 17th November 2014, the patient received BOOSTRIX. On an unknown date, an unknown time after BOOSTRIX, the patient experienced inappropriate age at vaccine administration. On an unknown date, the outcome of the inappropriate age at vaccine administration was unknown. It was unknown if the reporter considered the inappropriate age at vaccine to be related BOOSTRIX. Additional information received: A 15 months old male patient received an injection of BOOSTRIX. No other events noted or reported.
Redness at site 3x4cm and serpiginous pattern of hives/wheals on forearm, distal to site approx. 20cm in length. Left arm involvement only. Expected to recover.
This spontaneous report as received from a healthcare worker refers to an unspecified number of patients of unknown age and gender. No information regarding the patients' pertinent medical history, drug reactions or allergies and concomitant therapies was provided. On unknown dates, the patients received improperly stored doses of GARDASIL 9 lot # L037554, expiration date 25-DEC-2017 (doses and route of administration were not reported). There was no adverse effect reported. Administered doses of vaccine underwent the temperature excursion of 9 degree Celsius for 30 minutes which was detected by a data logger. There were no previous excursions reported. This is one of several reports received from the same reporter. Additional information has been requested.; Sender's Comments: US-009507513-1701USA014067: US-009507513-1701USA014075: US-009507513-1701USA014062:
10/31 First day felt a little sweaty. Next three days short of breath and cold sweats. Didn't feel good all of November. Had a slight cough that really got bad by Jan. Had to call Dr. and was prescribed ZITHROMAX and cough meds. Saw Dr. on Jan. 30 was told not to get another flu shot.
Dizzy Spell after 1st vaccine on scene; Fatigue for 2 days; This is a spontaneous report from a non-contactable consumer (patient). A patient of unspecified age and gender received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as SINGLE DOSE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced dizzy Spell after 1st vaccine on scene and fatigue for 2 days. The outcome was unknown.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
I was given Zostavax and developed a case of Shingles on my right hand the next day. It was initially misdiagnosed as poison ivy, so treatment with valacyclovir was not begun until 8/16.  I'm still recovering from the shingles, and it has significantly exacerbated a preexisting carpal tunnel syndrome condition.
DIZZY; HEADACHE; NAUSEA; TIREDNESS; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: not reported) dose was not reported, administered on 20-MAR-2021 for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported.  On MAR-2021, the subject experienced dizzy. On MAR-2021, the subject experienced headache. On MAR-2021, the subject experienced nausea. On MAR-2021, the subject experienced tiredness. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the headache, nausea, tiredness and dizzy was not reported. This report was non-serious.
erythema; hives, t98.4 oral; tx DPH PO; Seldane PO; Diprolene cream; cool compresses;